Pablo Coto

620 total citations
22 papers, 332 citations indexed

About

Pablo Coto is a scholar working on Immunology, Rheumatology and Hematology. According to data from OpenAlex, Pablo Coto has authored 22 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 12 papers in Rheumatology and 6 papers in Hematology. Recurrent topics in Pablo Coto's work include Psoriasis: Treatment and Pathogenesis (16 papers), Spondyloarthritis Studies and Treatments (12 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Pablo Coto is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (16 papers), Spondyloarthritis Studies and Treatments (12 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Pablo Coto collaborates with scholars based in Spain, France and Switzerland. Pablo Coto's co-authors include Rubén Queiró, Sara Alonso, Javier Ballina, Mercedes Alperí, Jesús Martı́nez-Borra, Carlos López‐Larrea, Cristina Sarasqueta, Segundo González, Cristina Sarasqueta and Eliécer Coto and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Pablo Coto

22 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Coto Spain 10 248 194 89 64 49 22 332
Jack Godsell Australia 6 171 0.7× 92 0.5× 23 0.3× 45 0.7× 40 0.8× 9 231
Ash Maroof United Kingdom 4 228 0.9× 114 0.6× 68 0.8× 73 1.1× 18 0.4× 5 270
Sutha Shanmugarajah Canada 8 531 2.1× 521 2.7× 295 3.3× 75 1.2× 31 0.6× 8 641
Andrea Everding United States 3 177 0.7× 271 1.4× 141 1.6× 14 0.2× 22 0.4× 5 318
Valdimar B. Hauksson Iceland 4 362 1.5× 111 0.6× 70 0.8× 152 2.4× 46 0.9× 5 431
V. Bruner Italy 7 95 0.4× 135 0.7× 34 0.4× 11 0.2× 72 1.5× 9 295
M. Turina Netherlands 9 233 0.9× 180 0.9× 64 0.7× 10 0.2× 74 1.5× 13 335
Jean-Pierre Cédoz France 7 85 0.3× 124 0.6× 39 0.4× 12 0.2× 33 0.7× 9 197
Rie Suematsu Japan 11 248 1.0× 99 0.5× 176 2.0× 14 0.2× 69 1.4× 18 343
Véronique Lamarque France 3 190 0.8× 56 0.3× 23 0.3× 131 2.0× 27 0.6× 7 288

Countries citing papers authored by Pablo Coto

Since Specialization
Citations

This map shows the geographic impact of Pablo Coto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Coto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Coto more than expected).

Fields of papers citing papers by Pablo Coto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Coto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Coto. The network helps show where Pablo Coto may publish in the future.

Co-authorship network of co-authors of Pablo Coto

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Coto. A scholar is included among the top collaborators of Pablo Coto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Coto. Pablo Coto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Queiró, Rubén, et al.. (2024). Influence of the HLA-Cw6 Allele and IFIH1/MDA5 Gene Variants on the Cardiometabolic Risk Profile of Patients with Psoriatic Disease. Journal of Clinical Medicine. 13(3). 845–845. 1 indexed citations
2.
Daudén, E., I. Belinchón, Pablo Coto, et al.. (2024). Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients. Scientific Reports. 14(1). 14519–14519. 2 indexed citations
3.
Coto, Pablo, et al.. (2020). Improving the standard of care for patients with spondyloarthritis-related immune inflammatory conditions: results of a Delphi study and proposal for early detection. Therapeutic Advances in Chronic Disease. 11. 1754196071–1754196071. 9 indexed citations
4.
Queiró, Rubén, et al.. (2019). Hypertension is associated with increased age at the onset of psoriasis and a higher body mass index in psoriatic disease. Clinical Rheumatology. 38(8). 2063–2068. 11 indexed citations
5.
Queiró, Rubén, et al.. (2019). Obesity in psoriatic arthritis. Medicine. 98(28). e16400–e16400. 41 indexed citations
6.
Queiró, Rubén, et al.. (2018). Prevalence and type II diabetes-associated factors in psoriatic arthritis. Clinical Rheumatology. 37(4). 1059–1064. 18 indexed citations
7.
Queiró, Rubén, et al.. (2018). Polyarticular evolution and late‐onset psoriasis may be associated with cardiovascular disease in psoriatic arthritis. International Journal of Rheumatic Diseases. 22(2). 269–274. 14 indexed citations
8.
Queiró, Rubén, et al.. (2018). Minimal Disease Activity and Patient-Acceptable Symptom State in Psoriatic Arthritis. JCR Journal of Clinical Rheumatology. 24(7). 381–384. 9 indexed citations
9.
Torre‐Alonso, Juan Carlos, Loreto Carmona, Mireia Moreno, et al.. (2017). Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain. Rheumatology International. 37(8). 1239–1248. 21 indexed citations
10.
Mencía, Ángeles, Marta García, Eva Jover, et al.. (2016). Identification of two rare and novel large deletions in ITGB4 gene causing epidermolysis bullosa with pyloric atresia. Experimental Dermatology. 25(4). 269–274. 11 indexed citations
11.
Cabezas‐Rodríguez, Iván, et al.. (2016). A polyarticular onset and diabetes could be the main predictors of cardiovascular events in psoriatic arthritis.. PubMed. 34(2). 276–81. 2 indexed citations
12.
Alonso, Sara, et al.. (2015). Age at disease onset may help to further characterize the disease phenotype in psoriatic arthritis. Joint Bone Spine. 83(5). 533–537. 26 indexed citations
13.
Coto, Pablo, et al.. (2014). Responsiveness of Service Discovery in Wireless Mesh Networks. 4909. 234–243. 1 indexed citations
14.
Queiró, Rubén, Sara Alonso, Pablo Coto, et al.. (2014). The Region Centromeric toHLA-CIs a Key Region for Understanding the Phenotypic Variability of Psoriatic Arthritis. SHILAP Revista de lepidopterología. 2014. 1–5. 4 indexed citations
15.
Queiró, Rubén, et al.. (2013). Age at disease onset: a key factor for understanding psoriatic disease. Lara D. Veeken. 53(7). 1178–1185. 89 indexed citations
17.
Santos‐Juanes, Jorge, Pablo Coto, & Cristina Galache. (2012). Ustekinumab. Neoplasias y otros aspectos de seguridad. Actas Dermo-Sifiliográficas. 103. 39–44. 3 indexed citations
18.
Esteban, Emilio, N. Villanueva, J. Fra, et al.. (2010). Activity of topotecan given intravenously for 5 days every three weeks in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes: a phase II study. Investigational New Drugs. 29(6). 1459–1464. 4 indexed citations
19.
Vázquez‐López, Francisco, et al.. (2006). Semiología cutánea: perspectiva histórica de la evolución de la terminología básica en España. Actas Dermo-Sifiliográficas. 97(3). 153–158. 1 indexed citations
20.
Losada, Antonio, et al.. (2006). Angiomas planos adquiridos en mancha de vino de Oporto. Actas Dermo-Sifiliográficas. 97(1). 62–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026